JAN 07, 2021 6:00 AM PST

Breath of Life: Nighttime Respiratory Rates Identify Which Heart Patients Need Surgery

WRITTEN BY: Tara Fernandez

Cardiovascular disease is the leading cause of death worldwide, taking nearly 18 million lives every year. Of these cardiac conditions, arrhythmia, or abnormal heartbeat rhythms, are among the most common problems. 

When it comes to heart rates, anything below 60 and above 100 beats per minute is considered dangerous. As a therapeutic strategy, patients with arrhythmia are protected from the potential of sudden cardiac death through the implantation of a device called a cardioverter defibrillator, or ICD. This battery-powered implant monitors for blips in heartbeat rhythms and sends out electrical impulses to counteract them. Newer-generations of these devices have an additional pacemaker function, stimulating the heart to beat faster when the rhythm detected starts to taper off.

The true value of ICDs to cardiac patients has, however, been a black box for cardiologists. It’s difficult to identify which patients would benefit most from the implantation of the device, particularly considering the risk of potential complications during the surgery. Now, scientists at the Technical University of Munich (TUM) have identified a biological metric to help predict whether a defibrillator will help, using the patients’ nighttime respiratory rate.

According to the experts, respiratory rates, in general, aren’t regularly tracked by cardiologists, but they should be. “The breathing rate has been largely ignored as a biosignal in the field of cardiology,” explained study lead Georg Schmidt.

“Our conclusions will now place a greater focus on this parameter. Especially in borderline cases, checking the patient’s breathing rate can help to decide on the right therapy.”

Over the course of four years, Schmidt and colleagues took respiratory and cardiac measurements of nearly 2,000 heart patients across various European cardiac hospitals. Roughly half of these underwent surgery to receive an ICD, and the other half were given non-surgical interventions. The team measured how participants breathed for 6 hours while they slept.

They found that overall, the patients with defibrillators had a 30 percent survival advantage over those who did not receive one. Interestingly, the team discovered a nexus between nocturnal respiratory rate and the effectiveness of ICDs. Patients with implants that took below 18 breaths per minute had a 50 percent survival advantage over the control group. However, those who took more frequent breaths did not have any added survival advantage with the implant.

This finding warrants larger, randomized studies to validate nocturnal respiratory rate as a marker for selecting patients best suited for ICD surgery, says Schmidt. 

“This would involve dividing the patients observed to gain no advantage from the ICD in our study into two groups, with one having an ICD implanted and the other receiving conservative treatment. If a randomized study of this kind reveals that heart patients with a higher nocturnal breathing rate do not benefit from the ICD implant, they could be spared this invasive treatment in the future.”

 

Sources: The Lancet, Technical University of Munich.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 10, 2021
Clinical & Molecular DX
New CRISPR Device Diagnoses COVID in an Hour, Detects Variants
AUG 10, 2021
New CRISPR Device Diagnoses COVID in an Hour, Detects Variants
A team of engineers from MIT and Harvard University has developed a COVID diagnostic device with a tiny footprint but hu ...
SEP 14, 2021
Health & Medicine
The Magnitude of Cardiovascular Disease- New Insights and Ways Forward
SEP 14, 2021
The Magnitude of Cardiovascular Disease- New Insights and Ways Forward
Among healthcare professionals, it is common knowledge that cardiovascular disease is the leading cause of death in the ...
OCT 06, 2021
Technology
New Sensor Could Detect Antibiotics In Your Breath
OCT 06, 2021
New Sensor Could Detect Antibiotics In Your Breath
Antibiotics are the cornerstone of treatment for bacterial infections. Though antibiotic resistance caused by the incorr ...
NOV 16, 2021
Clinical & Molecular DX
Still a Way to Go Before AI Can Help Patients on Ventilators
NOV 16, 2021
Still a Way to Go Before AI Can Help Patients on Ventilators
Computers aren’t ever going to replace doctors completely. Instead, artificial intelligence (AI) has the potential ...
NOV 18, 2021
Clinical & Molecular DX
Sequencing and AI Combo Powers Up ADHD Diagnostics
NOV 18, 2021
Sequencing and AI Combo Powers Up ADHD Diagnostics
Attention-deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders. Red flags signal ...
NOV 15, 2021
Health & Medicine
Alpha-synuclein as a Biomarker for Parkinson's Disease
NOV 15, 2021
Alpha-synuclein as a Biomarker for Parkinson's Disease
Parkinson’s disease (PD) is a widespread neurogenerative disorder that can significantly impact a person’s q ...
Loading Comments...